tiprankstipranks
Trending News
More News >
Rocket Pharmaceuticals (RCKT)
NASDAQ:RCKT
US Market

Rocket Pharmaceuticals (RCKT) Income Statement

Compare
1,384 Followers

Rocket Pharmaceuticals Income Statement

Last quarter (Q4 2024), Rocket Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Rocket Pharmaceuticals's net income was $-60.33M. See Rocket Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -7.10M$ -6.27M$ -5.37M$ -1.15M
Operating Expenses
$ 273.20M$ 259.66M$ 223.84M$ 166.25M$ 134.30M
Depreciation and Amortization
$ 0.00$ 7.10M$ 6.27M$ 5.37M$ 1.15M
EBITDA
$ -273.20M$ -236.62M$ -213.69M$ -161.72M$ -131.59M
Operating Income
$ -273.20M$ -259.66M$ -224.34M$ -167.25M$ -134.30M
Other Income/Expenses
$ 14.46M$ 14.06M$ 2.48M$ -1.82M$ -5.40M
Pretax Income
$ -258.75M$ -245.59M$ -221.86M$ -169.07M$ -139.70M
Net Income
$ -258.75M$ -245.59M$ -219.38M$ -169.59M$ -146.67M
Per Share Metrics
Basic EPS
$ -2.73$ -2.92$ -3.22$ -2.68$ -2.65
Diluted EPS
$ -2.73$ -2.92$ -3.22$ -2.68$ -2.65
Weighted Average Shares Outstanding
94.81M 84.01M 68.15M 63.24M 55.38M
Weighted Average Shares Outstanding (Diluted)
94.81M 84.01M 68.15M 63.24M 55.38M
Currency in USD

Rocket Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis